Wyoming Healthcare
Compliance Guide

Wyoming presents a generally favorable regulatory environment for healthcare companies, particularly those leveraging telehealth. The state is known for its business-friendly policies and a relatively less restrictive approach to healthcare innovation compared to many other states. Wyoming has historically embraced telehealth, recognizing its potential to improve access to care in its largely rural landscape. The primary regulatory bodies include the Wyoming Board of Medicine, the Wyoming State Board of Nursing, the Wyoming Board of Pharmacy, and the Wyoming Department of Health. Recent legislative actions have largely focused on solidifying telehealth parity and clarifying prescribing guidelines, rather than introducing significant new restrictions. For instance, Wyoming's professional licensing boards have generally adopted rules that facilitate telehealth practice, often aligning with federal guidelines where applicable. The state has also been proactive in joining interstate compacts, which streamlines the process for out-of-state providers. However, companies must still navigate specific state-level requirements, particularly concerning the establishment of a proper provider-patient relationship, informed consent, and adherence to professional scope of practice. While the Corporate Practice of Medicine (CPOM) doctrine is present, its enforcement is generally less aggressive than in some other states, offering more flexibility for non-physician ownership structures, though careful structuring is still paramount. Overall, Wyoming offers a welcoming climate for healthcare businesses, provided they meticulously adhere to professional licensing board regulations and the nuances of its CPOM interpretation.

Wyoming enforces the Corporate Practice of Medicine (CPOM) doctrine, though its application is generally considered moderate compared to more restrictive states. The legal basis for CPOM in Wyoming is primarily derived from professional licensing statutes that prohibit unlicensed individuals or entities from practicing medicine or employing licensed professionals to practice medicine on their behalf. For example, Wyoming Statute § 33-26-401(a)(i) defines the practice of medicine and surgery, and subsequent statutes implicitly restrict who can perform these acts and under what organizational structure. The Wyoming Board of Medicine has consistently interpreted these statutes to mean that only licensed physicians or professional medical corporations (PC) owned by physicians can employ other physicians or directly control the clinical decision-making of physicians. This means that a general business corporation cannot directly employ physicians or other licensed healthcare providers to deliver medical services. The purpose of CPOM is to protect the integrity of the physician-patient relationship and prevent lay interference in medical judgment. Non-physicians are generally prohibited from owning entities that directly provide medical services. However, Wyoming does permit certain structures that allow for non-physician investment and management, primarily through the Management Services Organization (MSO) model. An MSO, a non-licensed entity, can own the administrative and non-clinical assets of a practice (e.g., equipment, real estate, billing, marketing, HR) and provide these services to a physician-owned professional entity under a Management Services Agreement (MSA). The professional entity, which must be owned and controlled by licensed physicians, retains full control over all clinical decisions and patient care. This structure is critical for telehealth companies, medspas, dental practices, and wellness clinics looking to operate in Wyoming. For instance, a medspa offering medical services (e.g., injectables, laser treatments) must ensure the medical procedures are performed by or under the direct supervision of a licensed physician or appropriately supervised mid-level provider, and the entity providing these medical services is physician-owned. Dental practices typically operate under similar professional corporation requirements. Wellness clinics offering medical services (e.g., IV therapy, hormone therapy) must also adhere to this separation. While non-physicians cannot own the professional practice, they can own the MSO that provides administrative support. Fee-splitting rules are also relevant here, as any compensation structure between the MSO and the professional entity must not be tied to a percentage of clinical revenue, as this could be construed as illegal fee-splitting or an inducement for referrals. Instead, MSO fees should be based on fair market value for services rendered, such as a fixed fee or a cost-plus model. Careful legal structuring is essential to avoid CPOM violations and potential enforcement actions by the Wyoming Board of Medicine.

Wyoming has a progressive stance on telehealth, largely driven by its commitment to increasing access to care across its vast rural areas. The establishment of a proper provider-patient relationship via telehealth is generally permitted, provided it meets the same standard of care as an in-person encounter. Wyoming Statute § 33-26-101(a)(xvii) defines 'telehealth' broadly, encompassing various modalities. The Wyoming Board of Medicine's Rules and Regulations, Chapter 10, 'Telehealth,' provide specific guidance. A provider-patient relationship can be established through telehealth, including an initial consultation, as long as the physician obtains a medical history, performs a physical examination (to the extent possible and appropriate for the presenting complaint), and develops a treatment plan. The rules emphasize that the standard of care for telehealth services is the same as for in-person services. All modalities are generally permitted: live interactive audio-visual (video conferencing) is the preferred and most common method for establishing an initial relationship and conducting follow-up care. Audio-only (telephone) may be used when appropriate and clinically indicated, particularly for follow-up visits or in situations where video is not feasible, but generally not for establishing an initial relationship for prescribing controlled substances. Asynchronous (store-and-forward) technology is also permitted, particularly for specialties like dermatology or radiology, where images or data are transmitted for review at a later time. However, it must be sufficient to meet the standard of care. There are no specific telehealth registration requirements for providers beyond their standard professional licensure in Wyoming. Out-of-state providers must be licensed by the appropriate Wyoming board to practice telehealth with Wyoming patients. Wyoming is a member of the Interstate Medical Licensure Compact (IMLC), facilitating licensure for physicians. Informed consent is a critical component of telehealth practice in Wyoming. Prior to initiating telehealth services, providers must obtain informed consent from the patient, which should include information about the nature of telehealth, potential risks and benefits, privacy and security measures, and how to obtain follow-up care. This consent should be documented in the patient's medical record. There are no specific geographic restrictions within Wyoming for telehealth services; providers can treat patients anywhere in the state, provided they are licensed in Wyoming. However, providers must ensure they are practicing within their scope of practice and that the technology used is secure and HIPAA compliant.

Wyoming's prescribing rules for telehealth, particularly concerning controlled substances, are generally aligned with federal Drug Enforcement Administration (DEA) requirements and state board regulations. For non-controlled substances, prescribing via telehealth is permissible after a legitimate provider-patient relationship has been established and the standard of care is met, as outlined in the Wyoming Board of Medicine's Chapter 10 rules. For controlled substances, Wyoming Statute § 35-7-1031(a)(i) requires that controlled substances be prescribed for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. The key challenge for telehealth is the federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires an in-person medical evaluation before prescribing controlled substances via the internet. However, several exceptions exist, including during a public health emergency (PHE) waiver (which expired federally but state-specific rules may linger or be under review) or if the practitioner has conducted at least one in-person medical evaluation of the patient. The DEA has proposed new rules that would largely reinstate the in-person requirement, with limited exceptions. As of 2025-2026, providers should assume the in-person requirement for initial controlled substance prescriptions via telehealth, unless a specific, narrow exception applies or a new federal rule is finalized that permits it. Which schedules can be prescribed via telehealth? If the conditions for a legitimate medical purpose and established patient relationship are met (and any in-person exam requirement is satisfied), all schedules (II-V) can theoretically be prescribed. However, Schedule II substances face the highest scrutiny. DEA requirements: Providers must be registered with the DEA and hold a valid Wyoming medical license. The DEA registration must be linked to the physical location where the controlled substances are stored or dispensed, if applicable. PDMP checking: Wyoming Statute § 35-7-1060 mandates that prescribers check the Wyoming Prescription Drug Monitoring Program (PDMP) before prescribing Schedule II, III, or IV controlled substances. This check is required for initial prescriptions and at least every three months for ongoing therapy. This applies equally to telehealth encounters. Quantity or refill limitations: State and federal regulations impose limitations on quantities and refills, particularly for Schedule II substances (e.g., generally no refills for Schedule II, limited supply for acute pain). These apply regardless of whether the prescription originated via telehealth or in-person. Special rules for specific drug classes: For GLP-1s, testosterone, stimulants, and similar medications, while not controlled substances (except for some stimulants), they often require careful clinical assessment and monitoring. Wyoming boards expect the same rigorous evaluation via telehealth as in-person. For example, prescribing testosterone requires thorough endocrine evaluation, and GLP-1s for weight loss require comprehensive metabolic assessment. The standard of care demands appropriate diagnostic work-up and ongoing monitoring, which must be achievable through telehealth modalities used. Providers should be particularly cautious with 'lifestyle' medications that may be prone to diversion or misuse, ensuring robust patient screening and follow-up protocols.

Wyoming generally offers a progressive scope of practice for advanced practice registered nurses (APRNs) and physician assistants (PAs), reflecting the state's need to leverage these providers to expand access to care. Nurses (APRNs): Wyoming grants full practice authority to Certified Nurse Practitioners (CNPs), Certified Nurse Midwives (CNMs), and Clinical Nurse Specialists (CNSs), provided they meet specific educational and certification requirements. Wyoming Statute § 33-21-155 outlines the scope of practice for APRNs, allowing them to diagnose, treat, and prescribe within their area of specialty without direct physician supervision or a collaborative practice agreement. APRNs in Wyoming can independently prescribe controlled substances, provided they have met the requirements of the Wyoming Board of Nursing and the DEA. The Wyoming Board of Nursing's rules, particularly Chapter 5, 'Advanced Practice Registered Nurse Licensure,' detail these provisions. Physician Assistants (PAs): PAs in Wyoming operate under a 'supervision' model, but the degree of supervision is often less restrictive than in many other states. Wyoming Statute § 33-26-501 et seq. governs PA practice. PAs must have a supervising physician, and their scope of practice is defined by the supervising physician's scope of practice and the PA's education, experience, and competence, as outlined in a 'supervision agreement' filed with the Wyoming Board of Medicine. This agreement details the specific medical services the PA is authorized to perform, including prescribing medications, which can include controlled substances. While the supervising physician is ultimately responsible for the PA's actions, direct, on-site supervision is not always required, allowing for more autonomous practice in remote settings, including telehealth. Delegation rules for Medical Assistants (MAs) in Medspas: In Wyoming, Medical Assistants (MAs) generally perform administrative and clinical support tasks under the direct supervision of a physician or other licensed healthcare professional. They cannot independently perform procedures that constitute the practice of medicine or nursing. In medspas, procedures like injectables (e.g., Botox, dermal fillers), advanced laser treatments, and chemical peels are considered medical procedures and must be performed by or under the direct supervision of a licensed physician, APRN, or PA. MAs can assist with patient intake, prepare treatment rooms, and provide post-procedure care instructions, but cannot perform the procedures themselves. 'Direct supervision' typically means the supervising licensed professional is physically present in the facility and immediately available to provide assistance and direction. The Wyoming Board of Medicine and Board of Nursing would view any delegation of medical procedures to an unlicensed MA as a violation of professional practice acts. Other Mid-level Providers: Other licensed professionals, such as Registered Nurses (RNs) and Licensed Practical Nurses (LPNs), also have defined scopes of practice. RNs can perform delegated medical acts under physician supervision, but these acts must be within the scope of nursing and not constitute independent medical practice. LPNs have an even more limited scope, generally requiring direct supervision for many tasks. Any healthcare business must meticulously review the specific licensing board rules for each provider type to ensure compliance with delegation and supervision requirements.

Navigating business structuring in Wyoming requires careful consideration of the Corporate Practice of Medicine (CPOM) doctrine and fee-splitting prohibitions. The most common compliant structure for healthcare companies, especially those with non-physician ownership or investment, is the Professional Corporation (PC) - Management Services Organization (MSO) model. PC-MSO Structures: This model is essential when non-physicians seek to own or invest in a healthcare business that provides medical services. The Professional Corporation (PC), or a similar professional entity (e.g., Professional Limited Liability Company, PLLC), must be 100% owned by licensed healthcare professionals (e.g., physicians for a medical practice, dentists for a dental practice) who are licensed in Wyoming. This PC employs the licensed providers and delivers all clinical services. The Management Services Organization (MSO), which can be owned by non-physicians, is a separate entity that provides all non-clinical, administrative, and management services to the PC. These services include billing, scheduling, marketing, IT, real estate, equipment, and human resources for non-clinical staff. The relationship between the PC and MSO is governed by a Management Services Agreement (MSA). Management Services Agreement Requirements: The MSA is the cornerstone of the PC-MSO model. It must be structured to ensure the MSO does not exert control over clinical decision-making. Key elements include: * Fair Market Value (FMV) Compensation: The MSO's compensation from the PC must be based on the fair market value of the services provided, not a percentage of the PC's clinical revenue. Percentage-based fees can be interpreted as illegal fee-splitting or an inducement for referrals. Common FMV models include a fixed fee, cost-plus, or a percentage of gross collections that is clearly tied to the MSO's costs and services, not a share of professional fees. * Clinical Autonomy: The MSA must explicitly state that the PC retains sole authority over all clinical decisions, patient care, hiring/firing of clinical staff, and professional standards. * Term and Termination: Clear provisions for the term of the agreement and conditions for termination. Fee-Splitting Rules: Wyoming Statute § 33-26-402(a)(x) prohibits physicians from engaging in fee-splitting, which generally means sharing professional fees with an unlicensed person or entity for services rendered. This is why the MSO's compensation must be FMV for administrative services, not a share of medical fees. Professional Corporation Requirements: To form a PC in Wyoming, the entity must comply with Wyoming Statute § 17-2-101 et seq. (Professional Corporations Act) or § 17-29-101 et seq. (Professional Limited Liability Company Act). The articles of incorporation or organization must specify the professional service being rendered, and all shareholders/members must be licensed in the profession for which the PC is organized. How to Structure Ownership for Compliance: For telehealth companies, medspas, dental practices, or wellness clinics, the non-clinical assets and administrative functions can reside in the MSO (owned by investors/non-physicians), while the clinical services are delivered by a Wyoming-licensed professional entity (PC/PLLC) owned by Wyoming-licensed professionals. This separation is crucial. Any direct employment of physicians or other licensed practitioners by a general business corporation for the provision of medical services would likely violate Wyoming's CPOM doctrine. For dental practices, similar 'dental service organization' (DSO) models are common, where the DSO provides administrative services to a dentist-owned professional entity. Key takeaway: Always ensure the entity directly providing medical services is owned and controlled by licensed professionals, and any MSO relationship is strictly for administrative support at FMV, without clinical interference or illegal fee-splitting.*

Wyoming's legislative sessions in 2024-2026 have continued to refine its healthcare landscape, particularly concerning telehealth and interstate practice. While no seismic shifts have occurred, several key areas have seen developments or ongoing discussions: Telehealth Parity and Reimbursement: Wyoming continues to reinforce telehealth parity laws, ensuring that services delivered via telehealth are reimbursed at the same rate as in-person services by state-regulated health plans. While the initial legislative pushes for this occurred during the COVID-19 pandemic, ongoing efforts aim to make these provisions permanent and expand them to cover a broader range of services and payers. Bills introduced in the 2024 legislative session, such as HB0058 (related to health insurance coverage for telehealth), sought to clarify and strengthen these requirements, though specific outcomes vary. Interstate Compact Participation: Wyoming remains an active participant in several interstate compacts, significantly easing the burden for out-of-state providers. The state is a member of the Interstate Medical Licensure Compact (IMLC), the Nurse Licensure Compact (NLC), and the Physical Therapy Compact. Discussions are ongoing regarding participation in other compacts, such as the Psychology Interjurisdictional Compact (PSYPACT) or the Audiology and Speech-Language Pathology Interstate Compact (ASLP-IC), which would further expand telehealth capabilities for these professions. Controlled Substance Prescribing: Following the federal public health emergency (PHE) expiration, Wyoming's boards have largely reverted to pre-PHE rules for controlled substance prescribing via telehealth, emphasizing the need for an in-person exam or a valid exception under the Ryan Haight Act. The proposed federal DEA rules regarding telehealth prescribing of controlled substances are closely monitored, and Wyoming boards are expected to align their guidance once federal rules are finalized. Board Actions and Enforcement: The Wyoming Board of Medicine and Board of Nursing regularly issue guidance and take enforcement actions related to professional misconduct, including inappropriate prescribing, failure to maintain the standard of care, and violations of CPOM. While specific cases are confidential, recent trends indicate an increased focus on ensuring that telehealth providers adhere to the same rigorous standards as in-person practitioners, particularly regarding patient assessment, documentation, and informed consent. Data Privacy and Security: With the increasing reliance on digital health, discussions around strengthening data privacy and security measures beyond HIPAA have been noted, though no major state-level privacy legislation akin to California's CCPA has been enacted. However, healthcare companies should anticipate continued scrutiny of data handling practices.

For healthcare companies entering or expanding in Wyoming, a methodical approach to compliance is essential. Here's actionable guidance: 1. Licensing First: * Provider Licensing: Ensure all individual providers (physicians, NPs, PAs, etc.) are properly licensed by their respective Wyoming professional board before seeing any Wyoming patients. Leverage interstate compacts (IMLC, NLC) if applicable. * Entity Registration: Register your business entity (e.g., LLC, Corporation, PC) with the Wyoming Secretary of State. If forming a Professional Corporation (PC) or PLLC, ensure it meets the specific professional entity requirements. 2. CPOM Compliance (PC-MSO Model): * Establish Separate Entities: Create a Wyoming-licensed Professional Corporation (PC/PLLC) owned by Wyoming-licensed professionals for clinical services. Form a separate Management Services Organization (MSO) for administrative functions. * Draft a Compliant MSA: Engage legal counsel experienced in Wyoming healthcare law to draft a robust Management Services Agreement (MSA) that clearly delineates clinical and administrative responsibilities and ensures MSO fees are at Fair Market Value, avoiding fee-splitting. 3. Telehealth Protocols: * Standard of Care: Develop internal protocols ensuring telehealth services meet the same standard of care as in-person care. This includes thorough patient assessment, diagnosis, and treatment planning. * Informed Consent: Implement a clear, documented informed consent process for all telehealth patients, explaining the nature, risks, benefits, and privacy of telehealth. * Technology: Utilize HIPAA-compliant technology for all telehealth interactions. * Prescribing: Adhere strictly to controlled substance prescribing rules, including the Ryan Haight Act and Wyoming's PDMP requirements. Assume an initial in-person exam is required for controlled substances unless a clear exception applies. 4. Scope of Practice Adherence: * Verify Authority: For each provider type (NPs, PAs, MAs), confirm their precise scope of practice and any supervision/collaboration requirements with their respective Wyoming board. * Delegation: Be extremely cautious with delegation of medical tasks, especially in medspas. Ensure only licensed professionals perform medical procedures, and MAs only assist within their defined, limited scope. 5. Reimbursement and Billing: * Payer Policies: Understand Wyoming's telehealth parity laws and specific payer policies for private and public (Medicaid) insurance. * Coding: Use appropriate CPT and HCPCS codes for telehealth services. 6. Ongoing Monitoring: * Regulatory Updates: Regularly monitor the Wyoming Board of Medicine, Board of Nursing, and Board of Pharmacy websites for rule changes, guidance, and enforcement actions. * Legal Counsel: Maintain ongoing relationships with legal counsel specializing in Wyoming healthcare compliance. Common Pitfalls to Avoid: * Assuming federal telehealth rules automatically apply to Wyoming. * Ignoring the nuances of Wyoming's CPOM doctrine. * Improperly delegating medical tasks to unlicensed personnel. * Failing to check the PDMP for controlled substance prescriptions. * Structuring MSO fees as a percentage of clinical revenue. Timeline Expectations: Licensing can take 3-6 months for new applicants. Entity formation is quicker (weeks). Establishing the PC-MSO structure and drafting agreements typically takes 1-3 months. Budget 6-12 months for a comprehensive, compliant launch.*